Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA
AUTOR(ES)
Fattal, Elias
FONTE
Blackwell Publishing Ltd
RESUMO
Antisense oligonucleotides and small interfering RNA have enormous potential for the treatment of a number of diseases, including cancer. However, several impediments to their widespread use as drugs still have to be overcome: in particular their lack of stability in physiological fluids and their poor penetration into cells. Association with or encapsulation within nano-and microsized drug delivery systems could help to solve these problems. In this review, we describe the progress that has been made using delivery systems composed of natural or synthetic polymers in the form of complexes, nanoparticles or microparticles.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2697810Documentos Relacionados
- Retroviral delivery of small interfering RNA into primary cells
- Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.
- Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo
- Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA
- Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers